Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma
Xiaomeng Zhang, Xin Yang, Yan Zhang, Ye Fan, Yingying Zhu. Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma. // Current Molecular Pharmacology. – 2026. – DOI: 10.1016/j.cmp.2026.09.009. – URL: https://doi.org/10.1016/j.cmp.2026.09.009
Xiaomeng Zhang, Xin Yang, Yan Zhang, Ye Fan, & Yingying Zhu (2026). Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma. Current Molecular Pharmacology. https://doi.org/10.1016/j.cmp.2026.09.009
Xiaomeng Zhang, et al. “Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma.” Current Molecular Pharmacology, 2026. doi:10.1016/j.cmp.2026.09.009.
@article{Zhang2026,
title = {Validation of Interferon Regulatory Factor 1 and Nicotinamide Phosphoribosyltransferase as Prognostic Biomarkers and Potential Therapeutic Targets in Clear Cell Renal Cell Carcinoma},
author = {Zhang, Xiaomeng and Yang, Xin and Zhang, Yan and Fan, Ye and Zhu, Yingying},
journal = {Current Molecular Pharmacology},
year = {2026},
doi = {10.1016/j.cmp.2026.09.009},
url = {https://doi.org/10.1016/j.cmp.2026.09.009}
}